Scientists unveil surprising human vs. mouse differences in a major cancer immunotherapy target
Since its discovery in the 1990s, programmed cell death protein 1 (PD-1) has been regarded as a leading target in cancer ...
The University of Chicago Chronicle2y
Cancer immunotherapy, explained
Allison and Japanese immunologist Tasuku Honjo were jointly awarded the Nobel Prize for their work that led to the development of checkpoint inhibitors. Another type of immunotherapy known as cellular ...
BBC6y
Nobel prize for medicine goes to cancer therapy
"The booming field of immunotherapy that these discoveries ... Medicine is the first of the Nobel Prizes awarded each year. The literature prize will not be handed out this year, after the ...
Business Insider India6y
How the researchers who won the Nobel Prize in medicine transformed the way we treat cancer
had jointly won the Nobel Prize in Physiology or Medicine for their work in cancer immunotherapy. The two were instrumental in bringing about a new type of cancer treatment known as cancer ...
EurekAlert!29d
Therapeutic potential of a novel mixture of mRNA in nanoparticles overcomes tumor progression
The COVID-19 pandemic and recent Nobel Prize recognition have spotlighted ... and controlled immune activation, mRNA-based immunotherapy can encode proteins that stimulate the immune system ...
Nature2y
MD Anderson pursues the future of immunotherapy at new institute
Allison shared the Nobel Prize for Physiology or Medicine in 2018, and immunotherapy has been established as a new pillar of cancer care, alongside surgery, radiation, chemotherapy and targeted ...
University of Manchester6y
James Allison and Tasuku Honjo: deserving winners of this year's Nobel Prize in Physiology or Medicine
The 2018 Nobel Prize in Physiology or Medicine has been awarded to two ... led exciting and groundbreaking work on developing new types of immunotherapy that help our immune system fight cancer.
Business Wire1mon
Valora Therapeutics Raises $30 Million Seed Financing from Top Investors to Transform Immunotherapy with a Novel Glyco-immune Checkpoint Platform
SAN DIEGO--(BUSINESS WIRE)--Valora Therapeutics Inc. (“Valora”), a biotechnology company pioneering a novel approach to immunotherapy ... of the 2022 Nobel Prize in Chemistry, and a world ...